UY37915A - SPECIFIC ANTIBODIES FOR CD47 AND PD-L1 - Google Patents
SPECIFIC ANTIBODIES FOR CD47 AND PD-L1Info
- Publication number
- UY37915A UY37915A UY0001037915A UY37915A UY37915A UY 37915 A UY37915 A UY 37915A UY 0001037915 A UY0001037915 A UY 0001037915A UY 37915 A UY37915 A UY 37915A UY 37915 A UY37915 A UY 37915A
- Authority
- UY
- Uruguay
- Prior art keywords
- antibodies
- relates
- specific antibodies
- antibody
- present
- Prior art date
Links
Abstract
La presente invención se refiere a biotecnología, en particular a anticuerpos o fragmentos de unión al antígeno de los mismos y a su uso. Más particularmente, la presente invención se refiere a anticuerpos que se unen específicamente a CD47 y PD-L1. La invención se refiere también a ácido nucleico que codifica dicho anticuerpo o fragmento de unión al antígeno del mismo, un vector de expresión, un método para preparar dicho anticuerpo y al uso de dichos anticuerpos y composiciones en terapias contra el cáncer.The present invention relates to biotechnology, in particular to antibodies or antigen-binding fragments thereof and their use. More particularly, the present invention relates to antibodies that specifically bind to CD47 and PD-L1. The invention also relates to nucleic acid encoding said antibody or antigen binding fragment thereof, an expression vector, a method for preparing said antibody and the use of said antibodies and compositions in cancer therapies.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY0001037915A UY37915A (en) | 2018-10-03 | 2018-10-03 | SPECIFIC ANTIBODIES FOR CD47 AND PD-L1 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY0001037915A UY37915A (en) | 2018-10-03 | 2018-10-03 | SPECIFIC ANTIBODIES FOR CD47 AND PD-L1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY37915A true UY37915A (en) | 2019-04-30 |
Family
ID=66437161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001037915A UY37915A (en) | 2018-10-03 | 2018-10-03 | SPECIFIC ANTIBODIES FOR CD47 AND PD-L1 |
Country Status (1)
| Country | Link |
|---|---|
| UY (1) | UY37915A (en) |
-
2018
- 2018-10-03 UY UY0001037915A patent/UY37915A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP20024555A (en) | SPECIFIC ANTIBODIES FOR CD47 AND PD-L1 | |
| CO2017008462A2 (en) | Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies that specifically bind to cd3 and / or cd123 | |
| CL2017001328A1 (en) | Heterodimeric antibodies that bind cd3 and tumor antigens | |
| ECSP18023386A (en) | STROMAL THYMIC LYMPHOPOYETIN (TSLP) BINDING MOLECULES AND METHODS OF USE OF THE MOLECULES | |
| CO2019001367A2 (en) | Bispecific antibody type binding proteins that specifically bind to cd3 and cd123 | |
| PE20181013A1 (en) | BISPECIFIC ANTIBODY CONSTRUCTS THAT BIND EGFRVIII AND CD3 | |
| BR112018000696A2 (en) | antibody, methods for reducing and increasing the binding affinity of a human cd3 binding antibody, for treating and diagnosing a disease, for producing an antibody, and for detecting the presence of cd3 antigen, nucleic acid construct, expression vector, host cell, composition, and kit? | |
| CO2021014153A2 (en) | Monoclonal antibody that specifically binds to gitr | |
| BR112018070948A2 (en) | anti-psma antibodies and their use | |
| ECSP18084153A (en) | Humanized anti-BASIGIN antibodies and their use | |
| UY37683A (en) | MONOCLONAL ANTIBODY ANTI-PD-L1 MONOCLONAL | |
| UY37915A (en) | SPECIFIC ANTIBODIES FOR CD47 AND PD-L1 | |
| ECSP21028958A (en) | MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO CD20 ANTIGEN | |
| AR099604A1 (en) | METALOPROTEINASE MATRIX 9 ANTIBODIES AND THEIR METHODS OF USE |